Enhanced Expression of
CD40-CD40L
CLL
cytotoxic T cells
miR-181b
microRNA
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
12 Jan 2021
12 Jan 2021
Historique:
received:
12
12
2020
revised:
08
01
2021
accepted:
08
01
2021
entrez:
15
1
2021
pubmed:
16
1
2021
medline:
16
1
2021
Statut:
epublish
Résumé
The clinical progression of B cell chronic lymphocytic leukemia (CLL) is associated with immune cell dysfunction and a strong decrease of
Identifiants
pubmed: 33445508
pii: cancers13020257
doi: 10.3390/cancers13020257
pmc: PMC7826592
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Associazione Italiana per la Ricerca sul Cancro
ID : Start Up grant 2010 (10054)
Organisme : FP7 People: Marie-Curie Actions
ID : GA-2011-303735
Organisme : Italian Minister of Health
ID : GR-2016-02363070
Références
Physiol Rev. 2008 Jul;88(3):841-86
pubmed: 18626062
Nat Rev Cancer. 2017 May;17(5):286-301
pubmed: 28338065
Cell Death Differ. 2015 May;22(5):885-6
pubmed: 25849030
Nat Methods. 2011 Jun 26;8(8):659-61
pubmed: 21706014
Blood. 2000 Jun 15;95(12):3853-8
pubmed: 10845920
Cancer Res. 2012 Apr 1;72(7):1763-72
pubmed: 22350415
Annu Rev Immunol. 2001;19:683-765
pubmed: 11244051
Blood. 2015 Jul 23;126(4):445-53
pubmed: 26065654
Curr Opin Oncol. 2013 Nov;25(6):637-45
pubmed: 24076584
J Exp Med. 1995 Nov 1;182(5):1557-65
pubmed: 7595225
Cancer Lett. 2018 Sep 1;431:11-21
pubmed: 29800684
Oncotarget. 2015 Aug 14;6(23):19807-18
pubmed: 26090867
Cell Rep. 2013 Aug 15;4(3):566-77
pubmed: 23933259
N Engl J Med. 2011 Aug 25;365(8):725-33
pubmed: 21830940
Cancers (Basel). 2020 Mar 10;12(3):
pubmed: 32164276
Leuk Lymphoma. 2000 May;37(5-6):461-72
pubmed: 11042507
Blood. 2011 May 19;117(20):5463-72
pubmed: 21385850
Leuk Lymphoma. 2003 Mar;44(3):383-9
pubmed: 12688308
Oncotarget. 2012 Feb;3(2):195-202
pubmed: 22350310
Eur J Immunol. 2002 May;32(5):1403-13
pubmed: 11981828
Leuk Lymphoma. 2014 Mar;55(3):571-82
pubmed: 23697878
Cell. 2014 Jul 3;158(1):171-84
pubmed: 24954536
Cell Rep. 2016 Apr 5;15(1):9-18
pubmed: 27052167
Eur J Cancer. 2013 Sep;49(14):3055-63
pubmed: 23810250
Semin Cancer Biol. 2010 Dec;20(6):431-8
pubmed: 20920582
Trends Immunol. 2013 Dec;34(12):592-601
pubmed: 23928062
J Clin Invest. 2005 Jul;115(7):1797-805
pubmed: 15965501
Blood. 1997 Jun 1;89(11):4146-52
pubmed: 9166857
Cell Immunol. 1994 Dec;159(2):152-69
pubmed: 7994751
Leukemia. 2015 Jan;29(1):86-95
pubmed: 24732594
Immunol Rev. 2009 May;229(1):152-72
pubmed: 19426221
Hematol Oncol Clin North Am. 2013 Apr;27(2):173-206
pubmed: 23561469
Immunity. 2013 Jul 25;39(1):1-10
pubmed: 23890059
J Hematol Oncol. 2015 Feb 20;8:12
pubmed: 25886051
Lab Invest. 2009 Jun;89(6):708-16
pubmed: 19349957
Annu Rev Immunol. 1998;16:111-35
pubmed: 9597126
Cell. 1996 Oct 18;87(2):319-29
pubmed: 8861915
J Immunol. 1998 Feb 1;160(3):1106-15
pubmed: 9570523
Nat Med. 1997 Sep;3(9):984-9
pubmed: 9288724
Blood. 2011 Sep 15;118(11):3072-9
pubmed: 21636858
Adv Immunol. 2006;90:51-81
pubmed: 16730261
Carcinogenesis. 2012 Jul;33(7):1294-301
pubmed: 22610076
Nature. 1998 Jun 4;393(6684):480-3
pubmed: 9624005
J Immunol. 2007 Feb 1;178(3):1581-8
pubmed: 17237407
Neurobiol Aging. 2012 Nov;33(11):2599-611
pubmed: 22330173
Blood. 2001 Jan 1;97(1):256-63
pubmed: 11133769
Blood. 2009 Oct 8;114(15):3255-64
pubmed: 19692702
J Clin Invest. 2008 Jul;118(7):2427-37
pubmed: 18551193